Catia Traversari

Fondazione IRCCS Istituto Neurologico Carlo Besta — Italy

Immunology and Microbiology · Life Sciences

52h-index16.6kcitations174works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(66), Immune Cell Function and Interaction(40), T-cell and B-cell Immunology(36), CAR-T cell therapy research(35), Virus-based gene therapy research(34)

Publications174 total

Polyclonal expansion of functional tumor-reactive lymphocytes infiltrating glioblastoma for personalized cell therapy
Nature Communications·2025Open Access
Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery
Stem Cell Research & Therapy·2025· 3 citedOpen Access
Polyclonal expansion of functional tumor-reactive lymphocyte infiltrating glioblastoma for personalized cell therapy
2025Open Access
Data from Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
2023Open Access
Data from Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
2023Open Access
Supplementary Figure 1 Legend from Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
2023Open Access
Supplementary Figure 6 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 3 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 4 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Methods, Figures Legends 1-7 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 2 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 5 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Data from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Table 1 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 2 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Table 1 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 7 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 5 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 7 from <i>De Novo</i> Design of a Tumor-Penetrating Peptide
2023Open Access
Supplementary Figure 1 Legend from Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Claudio Bordignon(28), Chiara Bonini(16), Vincenzo Russo(13), Fabio Ciceri(12), Thierry Boon(9), Pierre van der Bruggen(8), Attilio Bondanza(8), Maurilio Ponzoni(7), Christophe Lurquin(6), Etienne De Plaen(6), Claudio Doglioni(6), Zulma Magnani(6), Sarah Marktel(6), Silvano Rossini(5), Patrick Chomez(4), Francesca Sanvito(4), Paolo Servida(4), Katharina Fleischhauer(4), Marco Bregni(4), Daniela Maggioni(4)